3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
22
Myelodysplastic Syndromes
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Myeloproliferative Disorders
7
Leukemia
7
Lymphoma, Non-Hodgkin
6
Anemia, Refractory, with Excess of Blasts
6
Lymphoma
5
Leukemia, Myelomonocytic, Chronic
5
Hodgkin Disease
5
Multiple Myeloma
4
Graft vs Host Disease
4
Leukemia, Myelomonocytic, Juvenile
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Biphenotypic, Acute
3
Hematologic Neoplasms
3
Congenital Abnormalities
3
Waldenstrom Macroglobulinemia
2
Thrombocythemia, Essential
2
Sezary Syndrome
2
Recurrence
2
Primary Myelofibrosis
2
Precancerous Conditions
2
Polycythemia Vera
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Myelodysplastic-Myeloproliferative Diseases
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Follicular
2
Interventions
Magnetic Resonance Spectroscopy
6
Biopsy
6
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
4
Cisplatin
3
Carboplatin
3
tazemetostat
2
selpercatinib
2
larotrectinib
2
erdafitinib
2
entrectinib
2
ensartinib
2
cabozantinib
2
Topotecan
2
Temozolomide
2
Surveys and Questionnaires
2
Radiation
2
LY3023414
2
Gemcitabine
2
Etoposide
2
Cyclophosphamide
2
ulixertinib
1
tipifarnib
1
pegfilgrastim
1
palbociclib
1
olaparib
1
niraparib
1
mirdametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Busulfan
×
90 days
×
Clear all
No trials found.